Tsveta Milanova, Chief Commercial Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 3,362 shares at $35.54 ($119K) on 2025-03-03, disclosed to the SEC on 2025-03-04.
Scheduled sale ($119k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.54 | 1,681 | $60K | 50.0% |
| 2 | $35.54 | 1,681 | $60K | 50.0% |
| Total | $35.54 avg | 3,362 | $119K | 100% |
| Filing → |
| AGIO | SELL | 2026-01-07 | $78K | — | Filing → |
| AGIO | SELL | 2026-01-02 | $79K | — | Filing → |
| AGIO | SELL | 2025-06-26 | $186K | — | Filing → |